Your last GLP-1 injection is not the finish line. Most people need a maintenance plan to protect their results. Options include continuing at a lower dose, tapering off gradually, or stopping with a structured plan. The right path depends on your health history and goals.
What to expect: After stopping a GLP-1, appetite often returns and some weight regain is common. Staying on therapy or stepping down to a lower dose can help maintain results.
Returning appetite and some regain are driven by normal biology â your body defends its weight â not by a lack of willpower. The same anchors work whether you're on or off medication: protein at each meal, fiber daily, consistent meals, quality sleep, and regular movement.
Your options: Continue at a maintenance dose (these medications are approved for chronic use). Taper gradually by reducing your injection amount or extending time between doses. Stop with a structured nutrition and exercise plan.
Maintenance is not the same as microdosing. A maintenance plan means holding your current prescribed dose, or stepping it down gradually with your provider, so your results hold. Microdosing is a different choice: deliberately taking less than the standard dose, usually when active weight loss is not the goal. If you are curious about microdosing, see "What is microdosing a GLP-1?". Your provider will help you decide which path fits.
If tapering: Continue at your effective dose for at least one month after reaching your goal weight. Then reduce by .5mg - 1mg every 1-2 weeks, or extend time between injections from weekly to every 2-3 weeks. Monitor your weight and appetite throughout.
Lock in lifestyle habits: Regular meals with lean protein, fiber, and non-starchy vegetables. Minimize liquid calories and processed snacks. At least 150 minutes of moderate activity per week, including strength training. Quality sleep (7-9 hours).
Stay connected: Schedule a follow-up with your provider 1 and 3 months after your last dose. Weigh yourself weekly and track trends, not daily fluctuations.